会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • WATER DISPERSIBLE FILM
    • 水分散膜
    • WO2005034854A2
    • 2005-04-21
    • PCT/US2004/028178
    • 2004-08-30
    • NEW YORK BLOOD CENTER, INC.NEURATH, Alexander, RobertSTRICK, NathanLI, Yun-Yao
    • NEURATH, Alexander, RobertSTRICK, NathanLI, Yun-Yao
    • A61K
    • A61K31/716A61K9/0034A61K9/7007
    • A soft, pliable cellulose acetate phthalate (CAP) - hydroxypropyl cellulose (HPC) composite film is provided which is generated by casting from organic solvent mixtures containing ethanol. The film rapidly reduces the infectivity of several sexually transmitted disease pathogens, including the human immunodeficiency virus (HIV-1), herpesvirus (HSV), non-viral sexually transmitted disease pathogens (such as Neisseria gonorrhoeae, Haemophilus ducreyi, Chlamydia trachomatis and Treponema pallidum) and bacteria associated with bacterial vaginosis (BV). The film is converted into a gel/cream and thus does not have to be removed following application and use. In addition to being a topical microbicide, the film can be employed for the mucosal delivery of pharmaceuticals other than cellulose acetate phthalate.
    • 提供柔软易弯曲的邻苯二甲酸醋酸纤维素(CAP) - 羟丙基纤维素(HPC)复合膜,其由含乙醇的有机溶剂混合物浇铸而成。 该膜快速降低了几种性传播疾病病原体的传染性,包括人类免疫缺陷病毒(HIV-1),疱疹病毒(HSV),非病毒性传播疾病病原体(如淋病奈瑟菌,杜克雷嗜血杆菌,沙眼衣原体和梅毒螺旋体 )和与细菌性阴道病相关的细菌(BV)。 该膜被转换成凝胶/乳膏,因此在应用和使用后不必除去。 除了是一种局部用杀微生物剂之外,该膜还可用于除醋酸邻苯二甲酸纤维素之外的药物的粘膜输送。
    • 10. 发明公开
    • RAPIDLY DISPERSIBLE VAGINAL TABLET THAT PROVIDES A BIOADHESIVE GEL
    • 快速分散的阴道分泌片提供了一种生物凝胶
    • EP2146698A2
    • 2010-01-27
    • EP08756218.7
    • 2008-05-23
    • New York Blood Center, Inc.
    • STONE, AlanNEURATH, Alexander, RobertSTRICK, NathanJIANG, Shibo
    • A61K9/20A61K31/00
    • A61K9/0034A61K9/2018A61K31/00
    • A tablet for insertion into a vagina including 0.01 to 500 mg of a vaginal medication, such as a microbicide, such as cellulose acetate 1,2- benzenedicarboxylate (CAP); 100 to 500 mg of mannitol powder; 50 to 300 mg of inert microcrystalline cellulose; 10 to 80 mg of hydroxypropyl methylcellulose; 50 to 250 mg of glycerol and optionally 2 to 4 mg of at least one preservative which protects against microbicidal contamination and discourages the growth of yeast in the vagina. The tablet which includes CAP as the vaginal medication is vaginally administered before coitus in methods for preventing the sexual transmission of HIV- 1, HIV-2, herpesvirus, or an infection caused by Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Haemophilus ducreyi or Treponema pallidum. The tablet which includes CAP as the vaginal medication is vaginally administered to prevent or treat bacterial vaginosis.
    • 一种用于插入阴道的片剂,包括0.01-500mg阴道药物,如杀微生物剂,如1,2-苯二甲酸乙酸纤维素(CAP); 100至500毫克甘露糖醇粉末; 50至300mg的惰性微晶纤维素; 10至80mg的羟丙基甲基纤维素; 50至250mg的甘油和任选的2至4mg的至少一种防腐剂,其防止微生物污染并阻止阴道中酵母的生长。 包含CAP作为阴道用药的片剂在性交前用于预防HIV-1,HIV-2,疱疹病毒的性传播或由淋病奈瑟氏球菌,沙眼衣原体,阴道毛滴虫,杜克氏嗜血杆菌或梅毒螺旋体引起的感染的方法中阴道给药 梅毒螺旋体。 将包含CAP作为阴道用药的片剂阴道给药以预防或治疗细菌性阴道病。